Although it is tempting to hypothesize that persistent inflammation may downregulate LPL and hepatic lipase, whilst increasing ApoC-III in CVID, there is currently no data on these important regulators of TG and TG-rich lipoproteins (i.e., VLDL) in CVID. The gene discussed is LPL; the disease is common variable immunodeficiency.